B

Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315

Watchlist Manager
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Watchlist
Price: 15 HKD -1.7% Market Closed
Market Cap: 6B HKD
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

0
Revenue
+0%
Jun 30, 2024 800.6m
Dec 31, 2023 716.9m
Jun 30, 2023 631.6m
0
Operating Income
+0%
Jun 30, 2024 -147.9m
Dec 31, 2023 -306.1m
Jun 30, 2023 -474.4m
0
Net Income
+0%
Jun 30, 2024 -243.8m
Dec 31, 2023 -383m
Jun 30, 2023 -519.4m

Earnings Waterfall
Biocytogen Pharmaceuticals Beijing Co Ltd

Revenue
800.6m CNY
Cost of Revenue
-224.4m CNY
Gross Profit
576.2m CNY
Operating Expenses
-724m CNY
Operating Income
-147.9m CNY
Other Expenses
-96m CNY
Net Income
-243.8m CNY

Income Statement
Biocytogen Pharmaceuticals Beijing Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Millions
Ones
Thousands
Millions
Billions
TTM
Quarterly
Annual
TTM
Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
632
N/A
717
+14%
801
+12%
Gross Profit
Cost of Revenue
(171)
(211)
(224)
Gross Profit
460
N/A
506
+10%
576
+14%
Operating Income
Operating Expenses
(935)
(812)
(724)
Selling, General & Administrative
(329)
(349)
(347)
Research & Development
(619)
(474)
(388)
Other Operating Expenses
14
11
11
Operating Income
(474)
N/A
(306)
+35%
(148)
+52%
Pre-Tax Income
Interest Income Expense
23
(14)
(35)
Non-Reccuring Items
(6)
16
22
Total Other Income
(61)
(76)
(77)
Pre-Tax Income
(518)
N/A
(380)
+27%
(238)
+37%
Net Income
Tax Provision
(1)
(3)
(6)
Income from Continuing Operations
(519)
(383)
(244)
Income to Minority Interest
0
0
0
Net Income (Common)
(519)
N/A
(383)
+26%
(244)
+36%
EPS (Diluted)
-1.3
N/A
-0.96
+26%
-0.61
+36%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 242,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.